Medanta Q4 PAT falls 20%, revenue rises 15% on strong patient volume
Global Health reports Q4FY25 PAT drop to ₹101.4 crore on one-time expense; revenue up 15% to ₹931.2 crore; expansion plans include 550-bed Noida facility by FY26
Medanta’s international patient revenue rose 17 per cent Y-o-Y to ₹55.7 crore, contributing 6 per cent to total revenue in the March quarter.
2 min read Last Updated : May 16 2025 | 7:30 PM IST
Global Health Limited (GHL), which operates Medanta Hospitals, reported a 20.4 per cent year-on-year (Y-o-Y) drop in consolidated profit after tax (PAT) for the March quarter (Q4FY25) to ₹101.4 crore, down from ₹127.3 crore in the same period last year.
The company’s revenue from operations rose 15.2 per cent Y-o-Y to ₹931.2 crore in Q4FY25, compared to ₹808.6 crore in Q4FY24.
GHL stated that the decline in PAT was due to a non-recurring exceptional expense of ₹49.9 crore related to the merger of MHPL (Manipal’s Lucknow entity) with GHL.
Medanta also announced that it is on track to commence operations at its upcoming 550-bed hospital in Noida by the second quarter of FY26.
Commenting on the expansion, Pankaj Sahni, group chief executive officer (CEO) and director, said the move is part of a broader plan to add 1,000 beds over the next two years, enhancing Medanta’s capacity to serve growing patient demand.
On a consolidated basis, the company’s earnings before interest, tax, depreciation, and amortisation (Ebitda) rose 19.8 per cent to ₹247.6 crore in Q4FY25. Ebitda margins stood at 26 per cent, up from 24.8 per cent in Q3FY24.
For the December quarter, Global Health reported a 12.3 per cent Y-o-Y growth in average occupied bed days, with an occupancy rate of 61.3 per cent driven by increased bed capacity.
The company reported a marginal rise in average revenue per occupied bed (ARPOB) per day to ₹63,629 in Q4FY25, up 0.9 per cent from ₹63,063 in the same period last year.
Medanta’s international patient revenue rose 17 per cent Y-o-Y to ₹55.7 crore, contributing 6 per cent to total revenue in the March quarter.
On Friday, Global Health Limited’s stock fell 3.26 per cent, ending the day’s trade at ₹1,202.65 apiece on the Bombay Stock Exchange (BSE).
You’ve reached your limit of {{free_limit}} free articles this month. Subscribe now for unlimited access.